Keyword Analysis & Research: bcma
Keyword Research: People who searched bcma also searched
Search Results related to bcma on Search Engine
-
BAR CODE MEDICATION ADMINISTRATION (BCMA)
https://www.va.gov/vdl/documents/Clinical/Pharm-Bar_Code_Med_Admin_(BCMA)/PSB_3_UM_CHAPTERS_1_THRU_6.pdf
WEBBAR CODE MEDICATION ADMINISTRATION (BCMA) GUI USER MANUAL . Version 3.0 . September 2022 . Department of Veterans Affairs . Office of Information and Technology
DA: 25 PA: 55 MOZ Rank: 98
-
Targeting BCMA to treat multiple myeloma: What to know - Medical News Today
https://www.medicalnewstoday.com/articles/bcma-treatment-multiple-myeloma
WEBJun 30, 2022 · BCMA-targeted treatment is a type of chimeric antigen receptor (CAR T) cell therapy. This refers to a class of anticancer treatment. Therapies that target BCMA specifically attack cancer...
DA: 89 PA: 97 MOZ Rank: 3
-
B-cell maturation antigen - Wikipedia
https://en.wikipedia.org/wiki/B-cell_maturation_antigen
WEBB-cell maturation antigen ( BCMA or BCM ), also known as tumor necrosis factor receptor superfamily member 17 ( TNFRSF17 ), is a protein that in humans is encoded by the TNFRSF17 gene . TNFRSF17 is a cell surface receptor of the TNF receptor superfamily which recognizes B-cell activating factor (BAFF). [5] [6] [7]
DA: 31 PA: 93 MOZ Rank: 43
-
BCMA in Multiple Myeloma—A Promising Key to Therapy - PMC
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472544/
WEBSep 10, 2021 · BCMA is a member of the tumor necrosis factor receptor family with high expression in mature B-lymphocytes and plasma cells. Given the understanding of BCMA mechanism of action in MM, BCMA plays a promising role as a therapeutic target.
DA: 2 PA: 4 MOZ Rank: 50
-
BCMA-targeted immunotherapy for multiple myeloma
https://jhoonline.biomedcentral.com/articles/10.1186/s13045-020-00962-7
WEBOct 16, 2019 · BCMA is a type III transmembrane glycoprotein, with an extracellular N terminus containing a conserved motif of 6 cysteines and an intracellular tumor necrosis factor receptor-associated factor (TRAF) binding domain that triggers the activation of nuclear factor κ-light-chain enhancer of activated B cells (NF-κβ) signaling. Full size image.
DA: 9 PA: 49 MOZ Rank: 27
-
Barcode medication administration technology use in hospital …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606443/
WEBJul 20, 2021 · Introduction. Barcode medication administration (BCMA) can, if poorly implemented, cause disrupted workflow, increased workload and cause medication errors. Further exploration is needed of the causes of BCMA policy deviations. Objective.
DA: 80 PA: 14 MOZ Rank: 77
-
Implementation of Bar-Code Medication Administration to Reduce …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257885/
WEBNov 26, 2018 · To assess the impact of implementing bar-code medication administration (BCMA) technology on the rate of medication administration errors in the inpatient setting, specifically those that affect the patient and result in harm. Patients and Methods.
DA: 72 PA: 59 MOZ Rank: 70
-
BCMA-targeted immunotherapy for multiple myeloma - PubMed
https://pubmed.ncbi.nlm.nih.gov/32943087/
WEBSep 17, 2020 · PMCID: PMC7499842. DOI: 10.1186/s13045-020-00962-7. Abstract. B cell maturation antigen (BCMA) is a novel treatment target for multiple myeloma (MM) due to its highly selective expression in malignant plasma cells (PCs).
DA: 3 PA: 19 MOZ Rank: 18
-
B-cell maturation antigen (BCMA) in multiple myeloma: rationale …
https://www.nature.com/articles/s41375-020-0734-z
WEBFeb 13, 2020 · B-cell maturation antigen (BCMA) is preferentially expressed by mature B lymphocytes, and its overexpression and activation are associated with MM in preclinical models and humans,...
DA: 59 PA: 33 MOZ Rank: 73
-
B-cell maturation antigen expression across hematologic cancers…
https://www.nature.com/articles/s41408-020-0337-y
WEBJun 30, 2020 · B-cell maturation antigen (BCMA) plays a critical role in regulating B-cell proliferation and survival. There is evidence for BCMA expression in various hematologic malignancies,...
DA: 23 PA: 38 MOZ Rank: 81